370 related articles for article (PubMed ID: 22120775)
1. Pancreatic iron and glucose dysregulation in thalassemia major.
Noetzli LJ; Mittelman SD; Watanabe RM; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):155-60. PubMed ID: 22120775
[TBL] [Abstract][Full Text] [Related]
2. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
Suvarna J; Ingle H; Deshmukh CT
Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
[TBL] [Abstract][Full Text] [Related]
4. The Close Link of Pancreatic Iron With Glucose Metabolism and With Cardiac Complications in Thalassemia Major: A Large, Multicenter Observational Study.
Pepe A; Pistoia L; Gamberini MR; Cuccia L; Peluso A; Messina G; Spasiano A; Allò M; Bisconte MG; Putti MC; Casini T; Dello Iacono N; Celli M; Vitucci A; Giuliano P; Peritore G; Renne S; Righi R; Positano V; De Sanctis V; Meloni A
Diabetes Care; 2020 Nov; 43(11):2830-2839. PubMed ID: 32887708
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose tolerance in beta-thalassemia: assessment of risk factors.
Hafez M; Youssry I; El-Hamed FA; Ibrahim A
Hemoglobin; 2009; 33(2):101-8. PubMed ID: 19373585
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major.
Bas M; Gumruk F; Gonc N; Cetin M; Tuncer M; Hazırolan T; Yildirim G; Karabulut E; Unal S
Ann Hematol; 2015 Jul; 94(7):1099-104. PubMed ID: 25740381
[TBL] [Abstract][Full Text] [Related]
8. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
[TBL] [Abstract][Full Text] [Related]
9. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.
van der Zijl NJ; Goossens GH; Moors CC; van Raalte DH; Muskiet MH; Pouwels PJ; Blaak EE; Diamant M
J Clin Endocrinol Metab; 2011 Feb; 96(2):459-67. PubMed ID: 21084401
[TBL] [Abstract][Full Text] [Related]
10. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major.
Au WY; Lam WW; Chu W; Tam S; Wong WK; Liang R; Ha SY
Haematologica; 2008 Jan; 93(1):116-9. PubMed ID: 18166794
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and β cell function in patients with β-thalassemia major.
Ghergherehchi R; Habibzadeh A
Hemoglobin; 2015; 39(1):69-73. PubMed ID: 25572183
[TBL] [Abstract][Full Text] [Related]
12. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
Kattamis C; Ladis V; Tsoussis D; Kaloumenou I; Theodoridis C
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
[TBL] [Abstract][Full Text] [Related]
13. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion-sensitivity index-2 could be a novel marker in the identification of the role of pancreatic iron deposition on beta-cell function in thalassemia major.
Karadas N; Yurekli B; Bayraktaroglu S; Aydinok Y
Endocr J; 2019 Dec; 66(12):1093-1099. PubMed ID: 31527320
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
Meloni A; Restaino G; Missere M; De Marchi D; Positano V; Valeri G; Giuseppe D'Ascola D; Peluso A; Caterina Putti M; Lendini M; Giovanna Neri M; Midiri M; Sallustio G; Pepe A
Am J Hematol; 2015 Sep; 90(9):E189-90. PubMed ID: 26044155
[No Abstract] [Full Text] [Related]
16. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
[TBL] [Abstract][Full Text] [Related]
17. Effect of Iron Chelation Therapy on Glucose Metabolism in Non-Transfusion-Dependent Thalassaemia.
Chuansumrit A; Pengpis P; Mahachoklertwattana P; Sirachainan N; Poomthavorn P; Sungkarat W; Kadegasem P; Khlairit P; Wongwerawattanakoon P
Acta Haematol; 2017; 137(1):20-26. PubMed ID: 27838686
[TBL] [Abstract][Full Text] [Related]
18. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.
Platis O; Anagnostopoulos G; Farmaki K; Posantzis M; Gotsis E; Tolis G
Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():279-81. PubMed ID: 16462711
[TBL] [Abstract][Full Text] [Related]
19. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
[TBL] [Abstract][Full Text] [Related]
20. Cardiac iron overload in sickle-cell disease.
Meloni A; Puliyel M; Pepe A; Berdoukas V; Coates TD; Wood JC
Am J Hematol; 2014 Jul; 89(7):678-83. PubMed ID: 24664847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
